Accelerate to discover

Back to filter

Related topics

Cytek full Spectrum flow Cytometry webinar: Part II – panel design and troubleshooting

Cytek Biosciences

Jan 11, 2021

In this session, we will continue to look at full spectrum flow cytometry and look at considerations for fluorescence...

CQ1 webinar : optimizing high-content imaging of 3D models for drug discovery

Yokogawa

Jan 7, 2021

In vitro spheroid models are fast becoming the de facto standard for drug discovery applications, largely due to their...

High gain mode now available on the Amnis ImageStreamX Mk II

Luminex

Dec 31, 2020

Increase camera gain during data acquisition and dramatically increase photonic sensitivity with High Gain mode, a new...

EV imaging series: Using ONI super-resolution to characterize single-EVs

ONI

Dec 23, 2020

To date, researchers commonly use flow-based characterization methods, fluorescence imaging techniques and electron...

Jan 15, 2021

Coming in spring 2021, meet the Cytek Aurora CS

Cytek Biosciences

Dec 16, 2020

Ever wanted to take your full spectrum panel from your Cytek Aurora or Northern Lights cytometer and sort? Soon, you...

Bruker webinar: Ear evolution in fossil mammals

Bruker Biospin

Nov 27, 2020

Hearing is just one of the functions aside of providing balance. Even juveniles obtain a fully developed ear region...

ONI Nanoimager joins the fight against COVID-19

ONI

Nov 24, 2020

ONI is supporting the global effort into research and diagnostics to tackle the COVID-19 pandemic. ONI is currently...

Jan 15, 2021

Early immune response in mice immunized with inactivated vaccine against SARS-CoV-2

Cytek Biosciences

Nov 19, 2020

The development of a vaccine against COVID-19 is a hot topic for many research laboratories all over the world. Our aim...

Show all topics (10)

The evaluation of three digital PCR platforms for residual disease in chronic myeloid leukemia

Oct 11, 2016

Thursday, October 13, 2016, 5 pm CEST

Mary Alikian, Ph.D., Imperial Molecular Pathology laboratory and the Department of Haematology at Hammersmith Hospital, Imperial College London

The BCR-ABL1 fusion gene sequence is used to help diagnose and monitor treatment and recurrence for chronic myelogenous leukemia (CML). In fact, between 90-95% of diagnosed CML cases are BCR-ABL1-positive. While reverse transcription quantitative PCR (RT-qPCR) is the gold standard strategy for monitoring BCR-ABL1 transcripts, there can often be challenges with reproducibility due to the technology and workflow. Reverse-Transcription Digital PCR (RT-dPCR) is an adaptation of this method that could provide the robust and standardized workflow needed for patient stratification. In this webinar, Dr. Mary Alikian at Hammersmith Hospital, Imperial College London, discussed her team’s comparison of three different available dPCR platforms (ThermoFisher Scientific’s QuantStudio 3D System, Bio-Rad’s QX200 System and RainDance’s RainDrop System) and investigation of whether they could be applied to a clinical research setting to quantify BCR-ABL1 transcripts in CML patients. The team determined that only the RainDrop System was able to detect and quantitatively measure BCR-ABL1 transcripts in the <0.001% range at a level higher than the false positive rate in the control patient groups.

Register now

Technical breakthrough
Webinar

Related technologies: Digital PCR

Get more info

Regina Fillerová

Field application specialist

Regina

Fillerová

+420 731 127 718

Send Message

Brand profile

RainDance Technologies

RainDance company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases.

Related products

Capable of generating more than a billion reactions in a single day, the RainDrop system surpasses all existing technologies and establishes a new performance standard in sensitivity, quantitation and multiplexing.

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey